Article
Cancer Immunotherapy through Tissue Adhering Polymers
2023-03-24
Abstract excerpt
TLR 7/8 agonists are highly potent immunostimulators, though their clinical translation has been met with mixed success, due to their high toxicity as a result of an unregulated systemic immune activation. There is enormous potential to augment cancer immunotherapies with synthetic TLR 7/8 agonists, though a thorough control of pharmacokinetics and localization is needed for the general use of TLR 7/8 agonists in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6ccb056c-c871-531c-a6b9-d161fb545d4c
- DOI
- 10.1101/2023.03.23.533909
